Saturday, April 15, 2017

The Truth About Vaccines (TTAV) Episode 3 Recap and Episode 4 Airs Tonight

Episode 3 of The Truth About Vaccines aired last night and stays open til 8 PM tonight EST!

Episode 3: An Analysis of the MMR & DTaP Vaccines & Vaccinating for the Greater Good

Thoughts & Commentary:

And a few words from Ty Bollinger too.

Here are just a few of the things talked about in Episode 3:

- Who developed the MMR vaccine.
- How having a vaccinated child doesn’t necessarily stop outbreaks from happening.
- How Japan tried giving its population the MMR vaccine and have since stopped because of its ineffectiveness and health issues it caused.
- The potential link between autism and inflammatory bowel disease.
- What Dr. Andrew Wakefield’s investigation revealed in his 250 page report.
- Plus so much more

Can't find the 250 page report yet, but maybe something about it can be found here:

Episode 3 – Aired last night April 14th at 9:00 P.M. EDT

An Analysis of the MMR & DTaP Vaccines & Vaccinating for the Greater Good

Here is the MMR package insert:

Adverse reactions begin on page 6 and goes through page 8.  Might as well list them.

Page 6:


The following adverse reactions are listed in decreasing order of severity, without regard to causality,
within each body system category and have been reported during clinical trials, with use of the marketed vaccine, or with use of monovalent or bivalent vaccine containing measles, mumps, or rubella:
Body as a Whole
     Panniculitis; atypical measles; fever; syncope; headache; dizziness; malaise; irritability.
Cardiovascular System
Digestive System
     Pancreatitis; diarrhea; vomiting; parotitis; nausea.
Endocrine System
     Diabetes mellitus.
Hemic and Lymphatic System
     Thrombocytopenia (see WARNINGS, Thrombocytopenia); purpura; regional lymphadenopathy;

Page 7:

Immune System
     Anaphylaxis and anaphylactoid reactions have been reported as well as related phenomena such as
angioneurotic edema (including peripheral or facial edema) and bronchial spasm in individuals with or without an allergic history.
Musculoskeletal System
     Arthritis; arthralgia; myalgia.
     Arthralgia and/or arthritis (usually transient and rarely chronic), and polyneuritis are features of infection with wild-type rubella and vary in frequency and severity with age and sex, being greatest in adult females and least in prepubertal children. This type of involvement as well as myalgia and paresthesia, have also been reported following administration of MERUVAX II.
     Chronic arthritis has been associated with wild-type rubella infection and has been related to persistent virus and/or viral antigen isolated from body tissues. Only rarely have vaccine recipients developed chronic joint symptoms.
     Following vaccination in children, reactions in joints are uncommon and generally of brief duration. In women, incidence rates for arthritis and arthralgia are generally higher than those seen in children (children: 0-3%; women: 12-26%),{17,56,57} and the reactions tend to be more marked and of longer duration. Symptoms may persist for a matter of months or on rare occasions for years. In adolescent girls, the reactions appear to be intermediate in incidence between those seen in children and in adult women.
Even in women older than 35 years, these reactions are generally well tolerated and rarely interfere with normal activities.
Nervous System
     Encephalitis; encephalopathy; measles inclusion body encephalitis (MIBE) (see
CONTRAINDICATIONS); subacute sclerosing panencephalitis (SSPE); Guillain-Barré Syndrome (GBS); acute disseminated encephalomyelitis (ADEM); transverse myelitis; febrile convulsions; afebrile convulsions or seizures; ataxia; polyneuritis; polyneuropathy; ocular palsies; paresthesia.
     Encephalitis and encephalopathy have been reported approximately once for every 3 million doses of M-M-R II or measles-, mumps-, and rubella-containing vaccine administered since licensure of these vaccines.
  The risk of serious neurological disorders following live measles virus vaccine administration remains less than the risk of encephalitis and encephalopathy following infection with wild-type measles (1 per 1000 reported cases).{58,59}
     In severely immunocompromised individuals who have been inadvertently vaccinated with measlescontaining vaccine; measles inclusion body encephalitis, pneumonitis, and fatal outcome as a direct consequence of disseminated measles vaccine virus infection have been reported (see
CONTRAINDICATIONS). In this population, disseminated mumps and rubella vaccine virus infection have also been reported.
  There have been reports of subacute sclerosing panencephalitis (SSPE) in children who did not have a history of infection with wild-type measles but did receive measles vaccine. Some of these cases may have resulted from unrecognized measles in the first year of life or possibly from the measles vaccination.
Based on estimated nationwide measles vaccine distribution, the association of SSPE cases to measles vaccination is about one case per million vaccine doses distributed. This is far less than the association with infection with wild-type measles, 6-22 cases of SSPE per million cases of measles. The results of a retrospective case-controlled study conducted by the Centers for Disease Control and Prevention suggest that the overall effect of measles vaccine has been to protect against SSPE by preventing measles with its inherent higher risk of SSPE.{60}
     Cases of aseptic meningitis have been reported to VAERS following measles, mumps, and rubella
vaccination. Although a causal relationship between the Urabe strain of mumps vaccine and aseptic
meningitis has been shown, there is no evidence to link Jeryl Lynn™ mumps vaccine to aseptic
Respiratory System
     Pneumonia; pneumonitis (see CONTRAINDICATIONS); sore throat; cough; rhinitis.
     Stevens-Johnson syndrome; erythema multiforme; urticaria; rash; measles-like rash; pruritis.
Local reactions including burning/stinging at injection site; wheal and flare; redness (erythema);
swelling; induration; tenderness; vesiculation at injection site; Henoch-Schönlein purpura; acute
hemorrhagic edema of infancy.8

Page 8:

Special Senses — Ear
     Nerve deafness; otitis media.
Special Senses — Eye
     Retinitis; optic neuritis; papillitis; retrobulbar neuritis; conjunctivitis.
Urogenital System
     Epididymitis; orchitis.
     Death from various, and in some cases unknown, causes has been reported rarely following
vaccination with measles, mumps, and rubella vaccines; however, a causal relationship has not been
established in healthy individuals (see CONTRAINDICATIONS). No deaths or permanent sequelae were reported in a published post-marketing surveillance study in Finland involving 1.5 million children and adults who were vaccinated with M-M-R II during 1982 to 1993.{61}
     Under the National Childhood Vaccine Injury Act of 1986, health-care providers and manufacturers are required to record and report certain suspected adverse events occurring within specific time periods after vaccination. However, the U.S. Department of Health and Human Services (DHHS) has established a Vaccine Adverse Event Reporting System (VAERS) which will accept all reports of suspected events.{49}
A VAERS report form as well as information regarding reporting requirements can be obtained by calling VAERS 1-800-822-7967.


Tripedia Package Insert:

Pg 11
...'Adverse events reported during post-approval use of Tripedia vaccine include idiopathic thrombocytopenic purpura, SIDS, anaphylactic reaction, cellulitis, autism, convulsion/grand mal convulsion, encephalopathy, hypotonia, neuropathy, somnolence and apnea. Events were included in this list because of the seriousness or frequency of reporting. Because these events are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequencies or to establish a causal relationship to components of Tripedia vaccine.2

* The above is archived, as the original was pulled, so here are more archived versions.


Links to snapshots:


Some short recaps from some of Episode 3 speakers...

Dr. Paul Thomas, M.D.:

The Truth About Vaccines (TTAV) Episode 3:



Dr. Larry Palevsky M.D.:

The Truth About Vaccines (TTAV) Episode 3:



Dr. Brian S.Hooker PH.D:

The Truth About Vaccines (TTAV) Episode 3:


For those who didn't catch the 9pm kickoff, The Truth About Vaccines Episodes 1,2 & 3 will be available again during the replay.  Episode 4 starts soon.

To watch, follow this link:


Tonight begins Episode 4! 

Episode 4 – Airs on April 15th at 9:00 P.M. EDT
Examining Influenza, the HIB and Pneumococcal Vaccines & Herd Immunity



No comments: